YAP1 and osteosarcoma: Utilizing RNA sequencing, PCR, Western blotting and flow cytometry, this study has demonstrated that HDACis (TSA/NAM) enhance the chemosensitivity of osteosarcoma cell lines to VP16 via suppressing the Hippo/YAP signaling pathway.